The Effect of the Frequently Used Cinacalcet for pHPT during the COVID-19 Pandemic on Perioperative Decrease in Parathyroid Hormone

The Effect of the Frequently Used Cinacalcet for pHPT during the COVID-19 Pandemic on Perioperative Decrease in Parathyroid Hormone

Background: Cinacalcet is a calcimimetic drug that has increasingly been used as a bridging therapy for primary hyperparathyroidism (pHPT), especially during the COVID-19 pandemic. The aim of our study was to investigate if preoperative cinacalcet therapy affects intraoperative parathyroid hormone (...

Full description

Bibliographic Details
Main Authors: Olga Radulova-Mauersberger, Julia Keßler, Ulrich Keßler, Katrin Stange, Sandra Korn, Jürgen Weitz, Ulrich Bork
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Journal of Clinical Medicine
Subjects:
parathyroidectomy
pHPT
PTH
COVID-19
hypercalcemia
calcimimetic
Online Access:https://www.mdpi.com/2077-0383/11/7/2015

Similar Items

Similar Items